BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34547921)

  • 1. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy.
    Miest T; Khanna A; Sharma V; Hensley PJ; Campbell R; Thapa P; Zganjar A; Tollefson MK; Thompson RH; Frank I; Karnes RJ; Potretzke A; Matin SF; Murthy PB; Haber GP; Lee B; Boorjian SA
    J Urol; 2022 Feb; 207(2):284-292. PubMed ID: 34547921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Ureteral Stent Drainage Prior to Cystectomy Increase the Risk of Subsequent Upper Tract Urothelial Carcinoma and Ureteral Complications?
    Miest TS; Sharma V; Boeri L; Tollefson MK; Thompson RH; Boorjian SA; Frank I; Karnes RJ
    Urology; 2021 Jul; 153():215-220. PubMed ID: 32763318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
    Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
    Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
    Gakis G; Black PC; Bochner BH; Boorjian SA; Stenzl A; Thalmann GN; Kassouf W
    Eur Urol; 2017 Apr; 71(4):545-557. PubMed ID: 27720534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
    D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
    BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
    Kates M; Badalato GM; Gupta M; McKiernan JM
    BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.
    Tran W; Serio AM; Raj GV; Dalbagni G; Vickers AJ; Bochner BH; Herr H; Donat SM
    J Urol; 2008 Jan; 179(1):96-100. PubMed ID: 17997449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
    Petros FG; Choi W; Qi Y; Moss T; Li R; Su X; Guo CC; Czerniak B; Dinney C; McConkey DJ; Matin SF
    J Urol; 2021 Sep; 206(3):548-557. PubMed ID: 33881933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Naser-Tavakolian A; Ghodoussipour S; Djaladat H
    Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelial tumors of upper tract following treatment of primary bladder transitional cell carcinoma.
    Schwartz CB; Bekirov H; Melman A
    Urology; 1992 Dec; 40(6):509-11. PubMed ID: 1466103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative prognostic factors and atypical patterns of recurrence in patients with upper urinary tract urothelial carcinoma treated with laparoscopic radical nephroureterectomy.
    Carrion A; Huguet J; García-Cruz E; Izquierdo L; Mateu L; Musquera M; Ribal MJ; Alcaraz A
    Scand J Urol; 2016 Aug; 50(4):305-12. PubMed ID: 26926709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper tract transitional cell carcinoma following treatment of superficial bladder cancer with BCG.
    Miller EB; Eure GR; Schellhammer PF
    Urology; 1993 Jul; 42(1):26-30. PubMed ID: 8328123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).
    Soria F; Shariat SF; Lerner SP; Fritsche HM; Rink M; Kassouf W; Spiess PE; Lotan Y; Ye D; Fernández MI; Kikuchi E; Chade DC; Babjuk M; Grollman AP; Thalmann GN
    World J Urol; 2017 Mar; 35(3):379-387. PubMed ID: 27604375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.
    Novotny V; Froehner M; May M; Protzel C; Hergenröther K; Rink M; Chun FK; Fisch M; Roghmann F; Palisaar RJ; Noldus J; Gierth M; Fritsche HM; Burger M; Sikic D; Keck B; Wullich B; Nuhn P; Buchner A; Stief CG; Vallo S; Bartsch G; Haferkamp A; Bastian PJ; Hakenberg OW; Propping S; Aziz A
    World J Urol; 2015 Nov; 33(11):1753-61. PubMed ID: 25663359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper tract transitional cell carcinoma following cystectomy for bladder cancer.
    Huguet-Pérez J; Palou J; Millán-Rodríguez F; Salvador-Bayarri J; Villavicencio-Mavrich H; Vicente-Rodríguez J
    Eur Urol; 2001 Sep; 40(3):318-23. PubMed ID: 11684849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence.
    Kiss B; Furrer MA; Wuethrich PY; Burkhard FC; Thalmann GN; Roth B
    J Urol; 2017 Dec; 198(6):1263-1268. PubMed ID: 28603003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.